Carta a la directora
Necesidad de valorar el gasto farmacéutico y los resultados en salud obtenidos de manera conjunta
The need for joint evaluation of pharmaceutical expenditure and the health outcomes obtained
Javier Soto Álvarez
Departamento de Farmacoeconomía e Investigación de Resultados, Pfizer España, S.A., Madrid, España
Read
1242
Timeswas read the article
428
Total PDF
814
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 December | 36 | 10 | 46 |
| 2024 November | 62 | 36 | 98 |
| 2024 October | 58 | 35 | 93 |
| 2024 September | 50 | 24 | 74 |
| 2024 August | 53 | 29 | 82 |
| 2024 July | 46 | 25 | 71 |
| 2024 June | 40 | 17 | 57 |
| 2024 May | 49 | 26 | 75 |
| 2024 April | 34 | 30 | 64 |
| 2024 March | 39 | 25 | 64 |
| 2024 February | 35 | 38 | 73 |
| 2024 January | 37 | 20 | 57 |
| 2023 December | 23 | 8 | 31 |
| 2023 November | 32 | 19 | 51 |
| 2023 October | 32 | 15 | 47 |
| 2023 September | 47 | 11 | 58 |
| 2023 August | 35 | 13 | 48 |
| 2023 July | 41 | 22 | 63 |
| 2023 June | 43 | 12 | 55 |
| 2023 May | 22 | 13 | 35 |
Show all
